A unique collection of 182 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery; Bioactivity and safety confirmed by pre-clinical research and clinical trials, and most of them are approved to be marketed; Targets cover various cytokines including IL, CSF, IFN, TNF, TGF-beta family, growth factors, chemokine family, etc; Detailed compound information with structure, target, activity, IC50 value, and biological activity description; Structurally diverse, medicinally active, and cell permeable; NMR and HPLC validated to ensure high purity and quality;
